You have 9 free searches left this month | for more free features.

Metastatic Castration Resistant

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Jun 15, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Oct 23, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Sep 7, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Nov 13, 2023

Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • London, United Kingdom
    Institute of Cancer Research
Jan 31, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Enfortumab vedotin)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Enfortumab vedotin
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 24, 2023

Advanced Prostate Cancer Trial (HRS-5041)

Not yet recruiting
  • Advanced Prostate Cancer
  • (no location specified)
Jul 5, 2023

Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

Available
  • Castration-Resistant Prostatic Cancer
  • (no location specified)
Sep 11, 2023

Metastatic Castration-resistant Prostate Cancer Trial (Disitamab Vedotin(RC48-ADC))

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Disitamab Vedotin(RC48-ADC)
  • (no location specified)
Jul 13, 2023

Darolutamide, Enzalutamide and Apalutamide and How Well These

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Whippany, New Jersey
    Bayer
Aug 25, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Prostatic Neoplasms
  • (no location specified)
Nov 21, 2023

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Recruiting
  • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
  • PSMA radionuclide therapy
  • Dallas, Texas
    Methodist Dallas Medical Center
Aug 9, 2023

Metastatic Castration-resistant Prostate Cancer Trial in United States (BMS-986460)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Palo Alto, California
  • +7 more
Oct 10, 2023

Metastatic Castration-resistant Prostate Cancer Trial (Darolutamide, Docetaxel or cabazitaxel)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Feb 28, 2023

Hormone-refractory Prostate Cancer Trial (AMX-500)

Not yet recruiting
  • Hormone-refractory Prostate Cancer
  • (no location specified)
Aug 11, 2023

Metastatic Castration Resistant Prostate Cancer Trial in China (AC176)

Not yet recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Beijing, China
  • +4 more
Jan 4, 2023

Medicines Called Enzalutamide and Abiraterone in People With

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • New York, New York
    Pfizer Inc
Jul 21, 2023

Prostate Cancer Trial in Beijing, Nanjing (QLH12016)

Not yet recruiting
  • Prostate Cancer
  • Beijing, Beijign, China
  • +1 more
Jul 25, 2023

Prostatic Tumors, Castration-Resistant Trial in New York (TVB-2640, Enzalutamide)

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Feb 23, 2023

Metastatic Castration-resistant Prostate Cancer, mCRPC, Prostate Cancer Trial in Melbourne (Lutetium-177 PSMA-I&T, Radium-223)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 26, 2022

Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • New Haven, Connecticut
    Yale Cancer Center
Oct 20, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T
  • Oklahoma City, Oklahoma
    Stephenson's Cancer Center
Mar 28, 2023

Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Metastatic Cancer
  • (no location specified)
Aug 12, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Melbourne (Cabazitaxel, 177Lu-PSMA-617)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • mCRPC
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Jul 20, 2022

Called DEAR, to Learn More About Treatment With Darolutamide,

Active, not recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Whippany, New Jersey
    Bayer
Jan 13, 2023